Vespexx pushes Korea femtech global at Seoul summit

Vespexx gathered founders, clinicians and investors in Seoul on June 30 for Korea Femtech Summit 2026, spotlighting Korean women's health startups expanding into the US, India, Japan and beyond. The company also launched Femtech Korea to connect local startups with global partners and investors.

Why it matters: - Korean femtech is moving from a domestic niche to a global growth story, with startups already selling into the US and India. - The summit signaled growing interest from US investors in women’s health technology built in Korea. - Vespexx used the event to position Soonr and the broader Korean femtech ecosystem for cross-border expansion.

What happened: - Vespexx hosted Korea Femtech Summit 2026 on June 30 in Seoul. - The event brought together founders, clinicians and investors from Korea, Singapore, Canada and Japan. - The summit focused on how women’s health technology from Korea can scale internationally. - Vespexx announced Femtech Korea, an industry network designed to connect Korean femtech companies with global markets and partners. - Vespexx said the network will also serve as a bridge for cross-border collaboration.

The details: - Kakao Ventures' Jade Chung moderated a panel centered on Korean startups going global. - Vespexx Co-CEO Scarlett Joowon Jung said the company is entering the US with Soonr, its couples preconception health platform. - Kai Health CEO Hyejun Lee said the company has deployed its AI embryo-analysis software across more than 120 fertility clinics in India. - Endo Health Head of Design Karlie Hyeonjeong Koo said Glow, its AI coaching app, has a user base that is 98% women and is backed by US investors including a16z. - Lindsay Davis, founder of FemTech Association Asia, opened the program with an update on Asia’s femtech landscape. - Dr. Juhye Lee of Ewha Womans University Mokdong Hospital spoke about women’s health moving beyond pregnancy and treatment toward care across the full life course. - Boram Bae, Head of Digital Health PM Part at Samsung Electronics, discussed how global consumer platforms can connect everyday health data with life-stage care. - Rimi Lee, head of the Femtech Center at KOSDAQ-listed diagnostics company Sugentech, described the shift from eye-read hormone tests to AI-assisted analysis. - Rimi Lee also pointed to wearable continuous hormone monitoring as a next frontier. - Jung presented Vespexx’s “dyadic health” approach on Soonr, which brings both partners into fertility and preconception care. - Vespexx said that approach is supported by Signaling, the company’s earlier product, which has 800,000 users across Asia. - Rachel Bartholomew, founder of Hyivy Health and Femtech Across Borders, shared the path behind her pelvic-health company. - Megumi Kimura of the Japan Women's Health Innovation Association outlined the investment and business models behind Japan’s femtech market. - The summit was hosted by Vespexx and co-hosted by FemTech Association Asia. - Sugentech sponsored the summit, with additional support from Innerness and Octolabs.

Between the lines: - The lineup showed that Korean femtech is not just building point solutions, but also trying to define a broader category around fertility, hormones and lifecycle care. - AI appeared to be the clearest technical edge across the summit, from embryo analysis to coaching and hormone monitoring. - Vespexx’s emphasis on partners and preconception care suggests a push to differentiate from women’s health products that focus only on the female user. - The launch of Femtech Korea points to a market-building effort as much as a business move, with ecosystem coordination now part of the expansion strategy.

What's next: - Vespexx is expanding Soonr into North America. - Femtech Korea is expected to link Korean startups with overseas partners and investors. - The companies highlighted at the summit are likely to use global validation, especially in the US, to support further fundraising and market entry. - The summit framed US partners and investors as a target audience for the next phase of Korea’s femtech growth.

The bottom line: - Korea’s femtech sector is trying to turn local healthcare know-how into global products, and Vespexx wants to help lead that push.